| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2025 | Nov 25, 2025 | NEKTAR THERAPEUTICS | Chief Legal Officer | Sell | 86.3 | +1,273 | 6.27% | ✗ | $34.2K |
| Aug 19, 2025 | Aug 21, 2025 | NEKTAR THERAPEUTICS | Chief Legal Officer | Sell | 46.3 | -676 | -3.22% | ✗ | $18K |
| May 19, 2025 | May 21, 2025 | NEKTAR THERAPEUTICS | Chief Legal Officer | Sell | 47.5 | -9,996 | -3.08% | ✗ | $6.7K |
| Feb 19, 2025 | Feb 21, 2025 | NEKTAR THERAPEUTICS | Chief Legal Officer | Sell | 46.3 | -11,040 | -3.29% | ✗ | $11.2K |
| Dec 23, 2024 | Dec 26, 2024 | NEKTAR THERAPEUTICS | Chief Legal Officer | Sell | 46.3 | -49,962 | -12.97% | ✗ | $44.8K |
| Nov 19, 2024 | Nov 20, 2024 | NEKTAR THERAPEUTICS | Chief Legal Officer | Sell | 47.5 | -6,407 | -2.84% | ✗ | $6.5K |
| Aug 19, 2024 | Aug 20, 2024 | NEKTAR THERAPEUTICS | Chief Legal Officer | Sell | 47.5 | -5,651 | -2.45% | ✗ | $7.2K |
| May 17, 2024 | May 20, 2024 | NEKTAR THERAPEUTICS | Chief Legal Officer | Sell | 46.3 | -6,260 | -2.64% | ✗ | $11K |
| Feb 20, 2024 | Feb 22, 2024 | NEKTAR THERAPEUTICS | Chief Legal Officer | Sell | 47.5 | -7,606 | -3.11% | ✗ | $5.2K |
| Nov 17, 2023 | Nov 20, 2023 | NEKTAR THERAPEUTICS | Chief Legal Officer | Sell | 47.5 | -7,179 | -2.86% | ✗ | $3.5K |
| Aug 16, 2023 | Aug 17, 2023 | NEKTAR THERAPEUTICS | Chief Legal Officer | Sell | 47.5 | -7,221 | -2.80% | ✗ | $5.6K |
| May 16, 2023 | May 17, 2023 | NEKTAR THERAPEUTICS | Chief Legal Officer | Sell | 47.5 | -7,543 | -2.84% | ✗ | $5.4K |
| Feb 16, 2023 | Feb 17, 2023 | NEKTAR THERAPEUTICS | Chief Legal Officer | Sell | 46.3 | -8,275 | -3.03% | ✗ | $24.8K |
| Nov 16, 2022 | Nov 18, 2022 | NEKTAR THERAPEUTICS | Chief Legal Officer | Sell | 46.3 | -8,690 | -3.09% | ✗ | $31K |
| Aug 15, 2022 | Aug 17, 2022 | NEKTAR THERAPEUTICS | SVP & General Counsel | Sell | 91.3 | +162,749 | 137.41% | ✗ | $15.2K |
| May 16, 2022 | May 17, 2022 | NEKTAR THERAPEUTICS | SVP & General Counsel | Sell | 46.3 | -3,136 | -2.59% | ✗ | $12.4K |
| Feb 16, 2022 | Feb 18, 2022 | NEKTAR THERAPEUTICS | SVP & General Counsel | Sell | 46.3 | -3,661 | -2.93% | ✗ | $40.1K |
| Nov 15, 2021 | Nov 17, 2021 | NEKTAR THERAPEUTICS | SVP & General Counsel | Sell | 95.0 | +13,536 | 18.57% | ✗ | $86.4K |
| Aug 16, 2021 | Aug 18, 2021 | NEKTAR THERAPEUTICS | SVP & General Counsel | Sell | 46.3 | -1,910 | -2.55% | ✗ | $26.4K |
| May 17, 2021 | May 19, 2021 | NEKTAR THERAPEUTICS | SVP & General Counsel | Sell | 46.3 | -1,917 | -2.50% | ✗ | $35.1K |
| Feb 16, 2021 | Feb 18, 2021 | NEKTAR THERAPEUTICS | SVP & General Counsel | Sell | 46.3 | -2,173 | -2.75% | ✗ | $48.6K |
| Feb 3, 2021 | Feb 4, 2021 | NEKTAR THERAPEUTICS | SVP & General Counsel | Sell | 32.5 | -5,344 | -6.34% | ✓ | $103.9K |
| Nov 16, 2020 | Nov 18, 2020 | NEKTAR THERAPEUTICS | SVP & General Counsel | Sell | 46.3 | -1,539 | -2.99% | ✗ | $26.1K |
| Aug 17, 2020 | Aug 19, 2020 | NEKTAR THERAPEUTICS | SVP & General Counsel | Sell | 46.3 | -1,529 | -2.89% | ✗ | $30.1K |
| May 18, 2020 | May 20, 2020 | NEKTAR THERAPEUTICS | SVP & General Counsel | Sell | 46.3 | -1,529 | -2.83% | ✗ | $34.4K |